Limited dose warfarin throughout pregnancy in patients with mechanical heart valve prosthesis: A meta-analysis

Interactive Cardiovascular and Thoracic Surgery

Volumn 18, Issue 6, 2014, Pages 797-806

  Hassouna, Ahmed ^a   Allam, Hemat ^b  

^a Saint Fatima Square Heliopolis   (Egypt)

^b NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Mechanical heart valve prosthesis; Oral anticoagulants; Pregnancy; Systematic review; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

CONFERENCE PAPER; CONTINUOUS INFUSION; DRUG DOSE REGIMEN; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EMBRYOPATHY; FETOMATERNAL TRANSFUSION; FETUS OUTCOME; FETUS WASTAGE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MATERNAL BLEEDING; MECHANICAL HEART VALVE; OUTCOME ASSESSMENT; POSTPARTUM HEMORRHAGE; PREGNANCY DISORDER; PREGNANCY OUTCOME; PREGNANCY RATE; PREMATURITY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROSTHETIC VALVE THROMBOSIS; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SPONTANEOUS ABORTION; SYSTEMATIC REVIEW; THROMBOEMBOLISM; BLOOD; BLOOD CLOTTING; DOSE RESPONSE; DRUG EFFECTS; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; META ANALYSIS; ORAL DRUG ADMINISTRATION; PATIENT SELECTION; PREGNANCY; PREGNANCY COMPLICATIONS; PROSTHESIS; THROMBOSIS; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANTICOAGULANTS; BLOOD COAGULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PATIENT SELECTION; PREGNANCY; PREGNANCY COMPLICATIONS; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTORS; THROMBOSIS; TREATMENT OUTCOME; WARFARIN;

EID: 84901464954     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivu009     Document Type: Conference Paper

References (25)

1. Cotrufo M, De Luc TSL, Calabro R, Mastrogiovanni G, Lama D. Coumarin anticoagulation during pregnancy in patients with mechanical valve prostheses. Eur J Cardiothorac Surg 1991;5:300-5.
2. Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: A systematic review of the literature. Arch Intern Med 2000;160:191-6.
3. Hassouna A, Allam H. Anticoagulation of pregnant women with mechanical heart valve prosthesis: A systematic review of the literature (2000-2009). J Coagul Disord 2010;2:81-8.
4. Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: The task force on the management of cardiovascular diseases during pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011;32:3147-97.
5. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgatner H et al. Guidelines on the management of valvular heart disease (version 2012). The joint task force on the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg 2012;42:S1-44.
6. Olkin I. Diagnostic statistical procedures in medical meta-analysis. Stat Med 1999;18:2331-41.
7. Vitale N, De Feo M, De Santo LS, Pollice A, Tedesco N, Cotrufo M. Dose dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 1999;33:637-1641.
8. Sadler L, McCowan L, White H, Stewart A, Bracken M, North R. Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves. BJOG 2000;107:245-53.
9. Al-Lawati AAM, Venkitraman M, Al-Delaime T, Valliathu J. Pregnancy and mechanical heart valves replacement; dilemma of anticoagulation. Eur J Cardiothorac Surg 2002;22:223-7.
10. Geelani MA, Singh S, Verma A, Nagesh A, Betigeri V, Nigam M. Anticoagulation in patients with mechanical valves during pregnancy. Asian Cardiovasc Thorac Ann 2005;13:30-3.
11. Khamooshi AJ, Kashfi F, Hoseini S, Tabatabaei MB, Javadpour H, Noohi F. Anticoagulation for prosthetic heart valves in pregnancy. Is there an answer? Asian Cardiovasc Thorac Ann 2007;15:493-6.
12. Akhtar RP, Abid AR, Zafar H, Cheema MA, Khan JS. Anticoagulation in pregnancy with mechanical heart valves: 10-year experience. Asian Cardiovasc Thorac Ann 2007;15:497-501.
13. Bian CE, Wei Q, Liu X. Influence of heart-valve replacement of warfarin anticoagulant therapy on perinatal outcomes. Arch Gynecol Obstet 2012; 285:347-51.
14. De Santo LS, Romano G, Della Corte A, D'Oria V, Nappi G, Giodarno S et al. Mechanical aortic valve replacement in young women planning on pregnancy maternal and fetal outcomes under low oral anticoagulation, a pilot observational study on a comprehensive pre-operative counseling protocol. J Am Coll Cardiol 2012;59:1110-5.
15. Basude S, Hein C, Curtis LS, Clark A, Trinder J. Low-molecular-weight heparin or warfarin for anticoagulation in pregnant patients with mechanical heart valves: what are the risks? A retrospective observational study. BJOG 2012;119:1008-13.
16. Hassouna A, Ammar A, Elnahas Y, Toema A, Allam H. Data on oral anticoagulation throughout pregnancy in 55 patients with mechanical valve prosthesis Provided to the Authors by Dr. Hassouna A, Research Unit Director, Department of Cardiothoracic Surgery. Cairo, Egypt: Ain Shams University 2013.
17. Bonow RO, Carabello BA, Chatterjee K, De Leon AC, Faxon DP, Freed MD et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: Executive summary a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation 2006;114:450-527.
18. Peiper PG, Balci A, Van Dijk AP. Pregnancy in women with prosthetic heart valves. Neth Heart J 2008;16:406-11.
19. McLintock C. Anticoagulant therapy in pregnant women with mechanical prosthetic heart valves: No easy option. Thromb Res 2011;127:S56-60.
20. Malik HT, Sepehripor AH, Shipolini AR, McCormack DJ. Is there a suitable method of anticoagulation in pregnant patients with mechanical prosthetic heart valves? Interact CardioVasc Thorac Surg 2012;15:484-8.
21. Bates SM, Geer IA, Middeldrop S, Veenstra DL, Prabulos A, Vandvik PO. VTE, thrombophilia, antithrombotic therapy and prevention of thrombosis, 9th ed. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141:e691S-736S.
22. Salazar E, Izaguire R, Verdejo J, Mutchinick O. Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve prostheses. J Am Coll Cardiol 1996;27:1698-703.
23. Lovenox injection (package insert). Bridgewater, NJ: Aventis Pharmaceuticals, 2002.
24. Elkayam U, Bitar F. Valvular heart diseases and pregnancy. Part II: prosthetic valves. J Am Coll Cardiol 2005;46:403-10.
25. Soma-Pillay P, Nene Z, Mathiyha TM, Macdonald AP. The effect of warfarin dosage on maternal and fetal outcomes in pregnant women with prosthetic heart valves. Obstet Med 2011;4:24-7.